Erlotinib Completed Phase 3 Trials for Fallopian Tube Cancer / Primary Peritoneal Cavity Cancer / Cancer of the Ovary Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00263822Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer